Linji Li

683 total citations · 1 hit paper
43 papers, 434 citations indexed

About

Linji Li is a scholar working on Anesthesiology and Pain Medicine, Critical Care and Intensive Care Medicine and Surgery. According to data from OpenAlex, Linji Li has authored 43 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Anesthesiology and Pain Medicine, 10 papers in Critical Care and Intensive Care Medicine and 8 papers in Surgery. Recurrent topics in Linji Li's work include Anesthesia and Sedative Agents (11 papers), Intensive Care Unit Cognitive Disorders (10 papers) and Anesthesia and Neurotoxicity Research (8 papers). Linji Li is often cited by papers focused on Anesthesia and Sedative Agents (11 papers), Intensive Care Unit Cognitive Disorders (10 papers) and Anesthesia and Neurotoxicity Research (8 papers). Linji Li collaborates with scholars based in China, United Kingdom and United States. Linji Li's co-authors include Cuihua Zhao, Chencheng Zhang, Wenbo Zhao, Hao Wu, Deshui Yu, Jiaojiao Zhou, Ying Xie, Yongli Shi, Xuechao Hao and Zhaoxin Zhang and has published in prestigious journals such as Scientific Reports, Coordination Chemistry Reviews and Chemical Engineering Journal.

In The Last Decade

Linji Li

39 papers receiving 426 citations

Hit Papers

Progress, challenge and perspective of graphite-based ano... 2024 2026 2025 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linji Li China 10 132 68 59 54 50 43 434
Chuanxi Chen China 9 304 2.3× 117 1.7× 20 0.3× 30 0.6× 17 0.3× 23 630
Shuangquan Qu China 10 96 0.7× 31 0.5× 31 0.5× 29 0.5× 13 0.3× 33 284
Xiangyang Guo China 10 28 0.2× 116 1.7× 22 0.4× 20 0.4× 12 0.2× 40 409
Xiao Rong China 14 119 0.9× 143 2.1× 22 0.4× 36 0.7× 25 0.5× 25 501
Xueying Zhang China 13 48 0.4× 191 2.8× 36 0.6× 37 0.7× 20 0.4× 24 436
Clive E.W. Hahn United Kingdom 17 276 2.1× 43 0.6× 3 0.1× 19 0.4× 20 0.4× 43 656
Shinsuke Inoue Japan 11 41 0.3× 106 1.6× 23 0.4× 35 0.6× 21 0.4× 30 458
Masahiro Imai Japan 5 33 0.3× 81 1.2× 104 1.8× 21 0.4× 41 0.8× 9 344
Anqi Wang China 11 46 0.3× 27 0.4× 11 0.2× 19 0.4× 11 0.2× 20 324
Mi Hyeon Lee South Korea 10 71 0.5× 398 5.9× 21 0.4× 33 0.6× 30 0.6× 23 741

Countries citing papers authored by Linji Li

Since Specialization
Citations

This map shows the geographic impact of Linji Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linji Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linji Li more than expected).

Fields of papers citing papers by Linji Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linji Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linji Li. The network helps show where Linji Li may publish in the future.

Co-authorship network of co-authors of Linji Li

This figure shows the co-authorship network connecting the top 25 collaborators of Linji Li. A scholar is included among the top collaborators of Linji Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linji Li. Linji Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Linji, et al.. (2025). Arginine N-glycosylation of melittin enhances its bacteriostatic activity and antiproliferative therapeutic index. Organic & Biomolecular Chemistry. 23(18). 4471–4479. 1 indexed citations
2.
Liu, Xianchun, Longyi Zhang, Li Zhao, et al.. (2025). Comparison of the safety of remimazolam and propofol during general anesthesia in elderly patients: systematic review and meta-analysis. Frontiers in Medicine. 12. 1409495–1409495. 1 indexed citations
3.
Zhang, Longyi, Shun Yang, Xianchun Liu, et al.. (2025). Impact of liposomal bupivacaine on subjective recovery quality after surgery: a meta-analysis of randomized controlled trials. Frontiers in Medicine. 12. 1655756–1655756.
4.
Zeng, Liang, Xianchun Liu, Longyi Zhang, et al.. (2025). Determination of the median effective dose of sufentanil combined with remimazolam in inhibiting tracheal intubation response. Scientific Reports. 15(1). 23635–23635.
5.
Zhao, Li, Ting Zhang, W. F. Mader, et al.. (2025). Determination of the Median Effective Dose of Ciprofol Combined with Sufentanil in Inhibiting Tracheal Intubation Response in Female Patients. Scientific Reports. 15(1). 11864–11864.
6.
Zhao, Li, et al.. (2025). The 50% effective dose of remimazolam combined with different doses of esketamine for painless gastroscopy. Scientific Reports. 15(1). 12770–12770. 1 indexed citations
7.
Zhang, Kai, Yongli Shi, Zhaoxin Zhang, et al.. (2025). Rapid removal of various recalcitrant pollutants from water by a pH-responsive high-swelling cyclodextrin polymer. Chemical Engineering Journal. 515. 163650–163650. 3 indexed citations
8.
He, Yanfei, Yongli Shi, Linji Li, et al.. (2025). Recent progress on the porous cyclodextrin polymers in water treatment. Coordination Chemistry Reviews. 541. 216826–216826. 4 indexed citations
9.
Zhang, Kai, Yongli Shi, Zhaoxin Zhang, et al.. (2025). Magnetic high-swelling cyclodextrin polymer adsorbent for rapid removal of pollutants and efficient recovery from water. Separation and Purification Technology. 366. 132741–132741. 5 indexed citations
10.
He, Yanfei, Yu Dai, Yongli Shi, et al.. (2024). Cyclodextrin membranes prepared by interfacial polymerization for separation. Chemical Engineering Journal. 492. 152165–152165. 21 indexed citations
12.
Zhang, Kai, Yu Dai, Yongli Shi, et al.. (2024). Cyclodextrin nanofilms with hydrophobic and hydrophilic channels for solvent permeation and molecular sieving. Nano Research. 17(7). 6638–6644. 4 indexed citations
14.
Li, Linji, et al.. (2024). Efficacy and Safety of Remimazolam Versus Etomidate for Induction of General Anesthesia: Protocol for a Systematic Review and Meta-Analysis. JMIR Research Protocols. 13. e55948–e55948. 1 indexed citations
15.
Zhao, Li, et al.. (2024). The research progress of perioperative non-pharmacological interventions on postoperative cognitive dysfunction: a narrative review. Frontiers in Neurology. 15. 1369821–1369821. 5 indexed citations
17.
Zhao, Cuihua, et al.. (2023). Influence of external electric field on electronic structure and optical properties of β-Ga2O3: a DFT study. RSC Advances. 13(39). 27568–27578. 4 indexed citations
18.
Liang, Xiao, Linji Li, & Yuchao Fan. (2022). Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis. Frontiers in Immunology. 13. 870726–870726. 8 indexed citations
19.
Jiang, Yanan, Si Chen, Linji Li, et al.. (2022). A toolbox of diverse arginine N-glycosylated peptides and specific antibodies. Bioorganic Chemistry. 130. 106267–106267. 6 indexed citations
20.
Li, Linji, et al.. (2022). Machine learning prediction of postoperative unplanned 30-day hospital readmission in older adult. Frontiers in Molecular Biosciences. 9. 910688–910688. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026